title: Understanding Primary Sclerosing Cholangitis: A Progressive Liver Condition
Primary sclerosing cholangitis (PSC) is a serious liver condition that affects between 5 and 16 in every 100,000 people. This progressive disease causes scarring of the bile ducts in the liver, leading to tissue damage and potentially liver failure over time.
There are three primary subtypes of PSC: classic, small duct, and autoimmune hepatitis-associated PSC. The classic type is the most common, affecting both small and large bile ducts. The small duct type only impacts small bile ducts and tends to have a better prognosis. The autoimmune hepatitis-associated type is generally less severe but has a worse prognosis than small duct PSC.
Symptoms of PSC vary depending on the stage of the condition. Common early symptoms include abdominal pain, itching, diarrhea, jaundice, fatigue, and fever. As the disease progresses, symptoms can worsen and may include ascites, hepatic encephalopathy, bleeding, edema, and weight loss.
Healthcare providers diagnose PSC through various tests, ruling out other potential causes of symptoms. Treatments focus on slowing disease progression and managing symptoms. Minimally invasive procedures, medications, and surgeries may be necessary, depending on the severity of the condition.
While there is no cure for PSC, lifestyle changes such as a healthy diet and limiting alcohol intake can help support liver health. Vitamin supplementation may also be recommended to prevent complications like osteoporosis.
PSC can lead to serious complications and increase the risk of conditions like inflammatory bowel disease, vitamin deficiency, osteoporosis, gallbladder diseases, cancer, biliary stricture, and cholangitis. Patients with PSC survive an average of 10-20 years after diagnosis, with some requiring a liver transplant.
Living with PSC can be challenging, but there are coping mechanisms available to help individuals manage the condition. Lastly, it’s important for patients to work closely with their healthcare providers to monitor and treat PSC effectively.